Navegar por autor "Manero, J."

Mostrando ítems 1-4 de 4

Clinical features and outcomes of COVID-19 in patients with rheumatic diseases treated with biological and synthetic targeted therapies

2020- Sanchez-Piedra, C.; Diaz-Torne, C.; Manero, J.; Pego Reigosa, José María; Rua-Figueroa, I.; [et al.]
Factors associated to persistence of treatment with golimumab in the biobadaser registry, with up to 6 years of follow-up

2019- POMBO SUAREZ, MANUEL ENRIQUE; Sanchez-Piedra, C.; Cuende, E.; Martin-Domenech, R.; del Pino, J.; [et al.]
Factors associated with long-term retention of treatment with golimumab in a real-world setting: an analysis of the Spanish BIOBADASER registry

2019- Hernandez, M. V.; Sanchez-Piedra, C.; Garcia-Magallon, B.; Cuende, E.; Manero, J.; [et al.]
Impact of age on the appearance of adverse eventsat the beginning of biological treatment: data from the BIOBADASER 3.0 registry

2019- Vela-Casasempere, P.; Sanchez-Piedra, C.; Perez-Garcia, C.; Arija, S. M.; Villegas, M. D. C.; [et al.]